T. Suwatanapongched, C. Nitiwarangkul, V. Arnuntasupakul, S. Kiertiburanakul
{"title":"Rama Co-RADS:改善泰国COVID-19患者管理和治疗沟通的尖端工具","authors":"T. Suwatanapongched, C. Nitiwarangkul, V. Arnuntasupakul, S. Kiertiburanakul","doi":"10.46475/aseanjr.v22i2.144","DOIUrl":null,"url":null,"abstract":"In Thailand, the rapid and constant rise in the number of confirmed COVID-19 cases, together with the increasing number of patients requiring respiratory and other medical life support during the third wave of COVID-19, has drastically overwhelmed the existing country’s healthcare facilities, physicians, and other healthcare workers. Hence, early identification of vulnerable patients at risk and early COVID-19 pneumonia is crucial for timely management and treatment by antivirals or corticosteroids to prevent them from developing severe COVID-19 pneumonia. A prompt chest X-ray report with clear and concise information at baseline screening in alternative healthcare facilities, especially in resource-constrained conditions, is essential. The article presents the incorporation of Rama Co-RADS (a categorical assessment scheme for chest X-ray findings for diagnosing pneumonia in patients with confirmed COVID-19). Its use facilitates a rapid, clear, and concise X-ray report despite the various levels of radiologists’ experience. Comprehensibleand consistent chest X-ray information successfully reduces the time lapse and communication gap among medical staff and assists on-duty, frontline physicians to make prompt and more accurate decisions regarding the management and treatment of COVID-19 patients in accordance with the current national guideline. ","PeriodicalId":180936,"journal":{"name":"The ASEAN Journal of Radiology","volume":"96 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Rama Co-RADS: Cutting-edge tool for improved communication in management and treatment of COVID-19 patients in Thailand\",\"authors\":\"T. Suwatanapongched, C. Nitiwarangkul, V. Arnuntasupakul, S. Kiertiburanakul\",\"doi\":\"10.46475/aseanjr.v22i2.144\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In Thailand, the rapid and constant rise in the number of confirmed COVID-19 cases, together with the increasing number of patients requiring respiratory and other medical life support during the third wave of COVID-19, has drastically overwhelmed the existing country’s healthcare facilities, physicians, and other healthcare workers. Hence, early identification of vulnerable patients at risk and early COVID-19 pneumonia is crucial for timely management and treatment by antivirals or corticosteroids to prevent them from developing severe COVID-19 pneumonia. A prompt chest X-ray report with clear and concise information at baseline screening in alternative healthcare facilities, especially in resource-constrained conditions, is essential. The article presents the incorporation of Rama Co-RADS (a categorical assessment scheme for chest X-ray findings for diagnosing pneumonia in patients with confirmed COVID-19). Its use facilitates a rapid, clear, and concise X-ray report despite the various levels of radiologists’ experience. Comprehensibleand consistent chest X-ray information successfully reduces the time lapse and communication gap among medical staff and assists on-duty, frontline physicians to make prompt and more accurate decisions regarding the management and treatment of COVID-19 patients in accordance with the current national guideline. \",\"PeriodicalId\":180936,\"journal\":{\"name\":\"The ASEAN Journal of Radiology\",\"volume\":\"96 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The ASEAN Journal of Radiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46475/aseanjr.v22i2.144\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The ASEAN Journal of Radiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46475/aseanjr.v22i2.144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Rama Co-RADS: Cutting-edge tool for improved communication in management and treatment of COVID-19 patients in Thailand
In Thailand, the rapid and constant rise in the number of confirmed COVID-19 cases, together with the increasing number of patients requiring respiratory and other medical life support during the third wave of COVID-19, has drastically overwhelmed the existing country’s healthcare facilities, physicians, and other healthcare workers. Hence, early identification of vulnerable patients at risk and early COVID-19 pneumonia is crucial for timely management and treatment by antivirals or corticosteroids to prevent them from developing severe COVID-19 pneumonia. A prompt chest X-ray report with clear and concise information at baseline screening in alternative healthcare facilities, especially in resource-constrained conditions, is essential. The article presents the incorporation of Rama Co-RADS (a categorical assessment scheme for chest X-ray findings for diagnosing pneumonia in patients with confirmed COVID-19). Its use facilitates a rapid, clear, and concise X-ray report despite the various levels of radiologists’ experience. Comprehensibleand consistent chest X-ray information successfully reduces the time lapse and communication gap among medical staff and assists on-duty, frontline physicians to make prompt and more accurate decisions regarding the management and treatment of COVID-19 patients in accordance with the current national guideline.